STAT - Reporting from the frontiers of health and medicine

Heavyweights

Health

First Opinion

By Nathalie Strub-Wourgaft

First Opinion OSHA’s ‘absurd reinterpretation’ of a regulation regarding workers and Covid-19
Biotech A new startup wants to use natural killer cells to fight cancer
Exclusive Raging at the pandemic, a VC raises $800M for a company that aims to transform biotech manufacturing
Health AstraZeneca Covid-19 vaccine is 70% effective on average, early data show
Special Report Data show hospitalized Covid-19 patients are surviving at higher rates, but surge in cases could roll back gains

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Health

Don't Miss

By STAT staff

Health Tech

By Juliet Isselbacher

Special Report

Health

By Gabrielle Glaser

Health

By Amy Sokolow

Heavyweights As a kid, his factory work paid for his dad’s cancer care. As an oncologist, his research offers more than survival
Special Report The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
Health AstraZeneca Covid-19 vaccine is 70% effective on average, early data show
Health ‘Essential workers’ likely to get earlier access to Covid-19 vaccine
Health The Covid-19 Tracker
Special Report Data show hospitalized Covid-19 patients are surviving at higher rates, but surge in cases could roll back gains
First Opinion OSHA’s ‘absurd reinterpretation’ of a regulation regarding workers and Covid-19
First Opinion CMS’s new rules on organ donation and transplantation ‘will bring chaos’